Rational mucolytic therapy in respiratory diseases: clinical interpretation of pharmacological properties for informed choice
Respiratory diseases remain a common group of diseases in the practice of general physicians and pulmonologists. Currently, there are various treatment protocols for patients with respiratory diseases, where one of the pharmacological groups is mucolytic drugs. They affect the physical and chemical...
Main Authors: | N. B. Lazareva, M. L. Maximov, I. V. Kukes |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2021-09-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6347 |
Similar Items
-
Mucolytics/antioxidants: When Are They Useful?
by: Mario Cazzola, et al.
Published: (2023-01-01) -
Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
by: Paola Rogliani, et al.
Published: (2019-05-01) -
Differentiated Approach to the Mucolytic Therapy for Respiratory Diseases in Children
by: Ye.I. Yulish
Published: (2013-10-01) -
Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy
by: Andrea Bianco, et al.
Published: (2022-11-01) -
Place of mucolytics in the treatment of acute sinusitis
by: A. I. Kryukov, et al.
Published: (2019-11-01)